ERBB2 and breast neoplasm: For instance, the SNVs in the PIK3CA gene associated with ∼20% of all breast tumors, have been utilized to predict resistance to trastuzumab treatment, wherein trastuzumab is a widely-used antibody drug for human epidermal growth factor receptor 2 (HER2) treatment [11].